BIOLASE Reports 2024 Second Quarter Results; Achieves 40% Gross Margin[...]
West Pharmaceutical Services Inc.
Amendment to Statement of Changes in Beneficial Ownership - Form 4/A
08/08/2024 | Press release | Distributed by Public on 08/08/2024 05:54
Please select the service you want to use:
Smartlinks | Hillenbrand Inc. | Finance | Security Markets | Security Markets | Company News | Top Company News | Corporate Debt | Corporate and Financial Calendar | Conference Calls and Webcasts | Financial Services | Investment Services | Securities Issuers | Industrial Equipment and Components Manufacturers | New York Stock Exchange (NYSE) | Frankfurt Stock Exchange | NYSE American | NYSE ARCA Equities | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | Investors Exchange (IEX) | Nasdaq BX | Nasdaq Intermarket | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact